New perspectives on contrast-induced nephropathy during coronary interventions.
Maad AlhudairyMohamed AbdelazeemJoe AounPublished in: Future cardiology (2022)
Tweetable abstract To reduce contrast-induced nephropathy as a complication of percutaneous coronary intervention, several thresholds have been proposed, including maximum contrast dose, contrast volume/estimated glomerular filtration rate, revised maximal contrast dose and zero-contrast percutaneous coronary intervention in select patients.
Keyphrases
- magnetic resonance
- percutaneous coronary intervention
- contrast enhanced
- coronary artery disease
- acute coronary syndrome
- acute myocardial infarction
- end stage renal disease
- st segment elevation myocardial infarction
- high glucose
- antiplatelet therapy
- diabetic rats
- chronic kidney disease
- coronary artery bypass grafting
- computed tomography
- drug induced
- left ventricular
- transcatheter aortic valve replacement
- body composition
- aortic stenosis